Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 703

1.

Impact of Clostridium difficile on inflammatory bowel disease.

Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):345-51.

PMID:
17368234
2.

The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.

Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C, Ross RP.

Am J Gastroenterol. 2009 May;104(5):1162-9. doi: 10.1038/ajg.2009.4. Epub 2009 Mar 24.

PMID:
19319128
3.

Clostridium difficile and inflammatory bowel disease.

Issa M, Ananthakrishnan AN, Binion DG.

Inflamm Bowel Dis. 2008 Oct;14(10):1432-42. doi: 10.1002/ibd.20500. Review.

PMID:
18484669
4.

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, Chermesh I, Al-Rifai A, Schoepfer A, Bosani M, Allez M, Lakatos PL, Bossa F, Eser A, Stefanelli T, Carbonnel F, Katsanos K, Checchin D, Miera IS, Chowers Y, Moran GW; European Crohn's and Colitis Organization (ECCO).

Clin Gastroenterol Hepatol. 2009 Sep;7(9):981-7. doi: 10.1016/j.cgh.2009.05.031. Epub 2009 Jun 10.

PMID:
19523534
5.

Impact of Clostridium difficile infection on pediatric inflammatory bowel disease.

Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A.

J Pediatr. 2009 Jun;154(6):854-8. doi: 10.1016/j.jpeds.2008.12.039. Epub 2009 Feb 23.

PMID:
19230908
6.

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.

Nguyen GC, Kaplan GG, Harris ML, Brant SR.

Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29.

PMID:
18513271
7.

Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.

Ott C, Girlich C, Klebl F, Plentz A, Iesalnieks I, Schölmerich J, Obermeier F.

Digestion. 2011;84(3):187-92. doi: 10.1159/000324617. Epub 2011 Jun 1.

PMID:
21646782
8.

Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.

Tremaine WJ.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):310-1. No abstract available.

PMID:
17368229
9.

Incidence of Clostridium difficile infection in inflammatory bowel disease.

Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):339-44.

PMID:
17368233
10.

Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Ananthakrishnan AN, McGinley EL, Binion DG.

Gut. 2008 Feb;57(2):205-10. Epub 2007 Sep 28.

PMID:
17905821
11.

Clostridium difficile and inflammatory bowel disease.

Ananthakrishnan AN, Issa M, Binion DG.

Gastroenterol Clin North Am. 2009 Dec;38(4):711-28. doi: 10.1016/j.gtc.2009.07.003. Review.

PMID:
19913210
12.

Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.

Hojsak I, Ferenc T, Bojanić K, Mišak Z, Močić Pavić A, Lukić-Grlić A, Kolaček S.

Digestion. 2012;86(1):6-11. doi: 10.1159/000337357. Epub 2012 Jun 8.

PMID:
22688504
13.

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors.

Banaszkiewicz A, Kowalska-Duplaga K, Pytrus T, Pituch H, Radzikowski A.

Inflamm Bowel Dis. 2012 May;18(5):844-8. doi: 10.1002/ibd.21837. Epub 2011 Sep 20.

PMID:
21936029
14.

Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG.

Ann Intern Med. 1995 Dec 1;123(11):835-40.

PMID:
7486465
15.

High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Komatsu M, Kato H, Aihara M, Shimakawa K, Iwasaki M, Nagasaka Y, Fukuda S, Matsuo S, Arakawa Y, Watanabe M, Iwatani Y.

Eur J Clin Microbiol Infect Dis. 2003 Sep;22(9):525-9. Epub 2003 Aug 21.

PMID:
12938013
16.

Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool.

Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS.

Eur J Gastroenterol Hepatol. 2004 Aug;16(8):775-8.

PMID:
15256979
17.

Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.

Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN.

Dis Colon Rectum. 2009 Jan;52(1):40-5. doi: 10.1007/DCR.0b013e31819733fd.

PMID:
19273954
18.

Basic epidemiology of inflammatory bowel disease in Puerto Rico.

Appleyard CB, Hernández G, Rios-Bedoya CF.

Inflamm Bowel Dis. 2004 Mar;10(2):106-11.

PMID:
15168809
19.

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

Wultańska D, Banaszkiewicz A, Radzikowski A, Obuch-Woszczatyński P, Młynarczyk G, Brazier JS, Pituch H, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1265-70. doi: 10.1007/s10096-010-0997-9. Epub 2010 Jun 26.

20.

Occurrence of Clostridium difficile toxin in inflammatory bowel disease.

Rolny P, Järnerot G, Möllby R.

Scand J Gastroenterol. 1983 Jan;18(1):61-4.

PMID:
6144171

Supplemental Content

Support Center